Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Simon Thelwall"'
Autor:
Wendy M. Rice, Dimple Y. Chudasama, James Lewis, Francis Senyah, Isaac Florence, Simon Thelwall, Lisa Glaser, Maciej Czachorowski, Emma Plugge, Hilary Kirkbride, Gavin Dabrera, Theresa Lamagni
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2183-2186 (2021)
Using laboratory data and a novel address matching methodology, we identified 734 cases of coronavirus disease in 88 prisons in England during March 16–October 12, 2020. An additional 412 cases were identified in prison staff and household members.
Externí odkaz:
https://doaj.org/article/d959185ad8904ef4b806ee7f854304e4
Autor:
Nurin Abdul Aziz, Sophie Grace Nash, Asad Zaidi, Tommy Nyberg, Natalie Groves, Russell Hope, Jamie Lopez Bernal, Gavin Dabrera, Simon Thelwall
Publikováno v:
Journal of Infection.
A recent study by Kang and colleagues (1) found that individuals infected with the SARS-CoV-2 BA.5 Omicron sub-lineage exhibited more severe symptoms at the onset of symptomatic disease but had a shorter viable virus shedding period compared to indiv
Publikováno v:
Journal of Hospital Infection. 120:73-80
BACKGROUND This article provides baseline epidemiological data on Pseudomonas spp. BSI in England for comparison against future findings from the mandatory surveillance of this infection, beginning April 2017. AIM We report trends in incidence, thirt
Autor:
Katie Harman, Sophie Grace Nash, Harriet H. Webster, Natalie Groves, Jo Hardstaff, Jessica Bridgen, Paula B. Blomquist, Russell Hope, Efejiro Ashano, Richard Myers, Sakib Rokadiya, Susan Hopkins, Colin S. Brown, Meera Chand, Gavin Dabrera, Simon Thelwall
ObjectivesSotrovimab is one of several therapeutic agents that have been licensed to treat people at risk of severe outcomes following COVID-19 infection. However, there are concerns that it has reduced efficacy to treat people with the BA.2 sub-line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10fab09024ed317dfb5877f83dec7769
https://doi.org/10.1101/2022.10.21.22281171
https://doi.org/10.1101/2022.10.21.22281171
Autor:
Jamie Lopez Bernal, Gavin Dabrera, Meera Chand, Natalie Groves, Gayatri Amirthalingam, Kevin E. Brown, Eileen Gallagher, Richard H. Myers, Susan Hopkins, Ruth Simmons, Mary Ramsay, Maria Zambon, Nick Andrews, Colin Campbell, Elise Tessier, Simon Thelwall, Charlotte Gower, Julia Stowe, Matt Edmunds
Publikováno v:
New England Journal of Medicine. 385:585-594
Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to ...
Autor:
James S. Lewis, Francis Senyah, Dimple Y Chudasama, Emma Plugge, Simon Thelwall, Isaac Florence, Hilary Kirkbride, Gavin Dabrera, Theresa Lamagni, Lisa Glaser, Wendy Rice, Maciej Czachorowski
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2183-2186 (2021)
Emerging Infectious Diseases
Emerging Infectious Diseases
Using laboratory data and a novel address matching methodology, we identified 734 cases of coronavirus disease in 88 prisons in England during March 16-October 12, 2020. An additional 412 cases were identified in prison staff and household members. W
Autor:
Tommy Nyberg, Neil M Ferguson, Joshua Blake, Wes Hinsley, Samir Bhatt, Daniela De Angelis, Simon Thelwall, Anne M Presanis
Publikováno v:
Lancet (London, England). 400(10355)
Autor:
Gavin, Dabrera, Hester, Allen, Asad, Zaidi, Joe, Flannagan, Katherine, Twohig, Simon, Thelwall, Elizabeth, Marchant, Nurin Abdul, Aziz, Theresa, Lamagni, Richard, Myers, André, Charlett, Fernando, Capelastegui, Dimple, Chudasama, Tom, Clare, Flavien, Coukan, Mary, Sinnathamby, Neil, Ferguson, Susan, Hopkins, Meera, Chand, Russell, Hope, Meaghan, Kall
Publikováno v:
Eurosurveillance. 27
Background The emergence of the SARS-CoV-2 Alpha variant in England coincided with a rapid increase in the number of PCR-confirmed COVID-19 cases in areas where the variant was concentrated. Aim Our aim was to assess whether infection with Alpha was
Autor:
Nick Andrews, Julia Stowe, Freja Kirsebom, Samuel Toffa, Tim Rickeard, Eileen Gallagher, Charlotte Gower, Meaghan Kall, Natalie Groves, Anne-Marie O’Connell, David Simons, Paula B. Blomquist, Asad Zaidi, Sophie Nash, Nurin Iwani Binti Abdul Aziz, Simon Thelwall, Gavin Dabrera, Richard Myers, Gayatri Amirthalingam, Saheer Gharbia, Jeffrey C. Barrett, Richard Elson, Shamez N. Ladhani, Neil Ferguson, Maria Zambon, Colin N.J. Campbell, Kevin Brown, Susan Hopkins, Meera Chand, Mary Ramsay, Jamie Lopez Bernal
BACKGROUND: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945f1f30b11bcae695c86f42a5422e2f
Autor:
Hester Allen, Elise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, Fernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, Sophie Nash, Simon Thelwall, Jamie Lopez-Bernal, Gavin Dabrera, André Charlett, Meaghan Kall, Theresa Lamagni
SummaryBackgroundThe SARS-CoV-2 Omicron variant (B.1.1.529) has rapidly replaced the Delta variant (B.1.617.2) to become dominant in England. This epidemiological study assessed differences in transmissibility between the Omicron and Delta using two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eba4663166490a360dc3495a3c9b867
https://doi.org/10.1101/2022.02.15.22271001
https://doi.org/10.1101/2022.02.15.22271001